Last updated on September 2018

Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Brief description of study

This Phase 1, open-label, multicenter study will investigate the safety and tolerability of RO7171009 following single and multiple intravitreal (ITV) administrations in patients with GA secondary to AMD. The study consists of two stages: Single Dose-Escalation (SAD) and Multiple-Dose (MD) stages.

Clinical Study Identifier: NCT03295877

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: GR39821 ...

Wolfe Eye Clinic
West Des Moines, IA United States